Richard Beira
Family Medicine · Bronx, NYNPI 1588692552
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,022 and has fallen 89.0% since, to $332 in 2022. Among family medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$674
- Johnson & Johnson$508
- Gilead$367
- Novo Nordisk$350
- AstraZeneca$320
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,73899%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 89 | $1,146 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 38 | $674 |
| Johnson & Johnson | 29 | $508 |
| Gilead | 18 | $367 |
| Novo Nordisk | 19 | $350 |
| AstraZeneca | 22 | $320 |
| GSK | 16 | $297 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $257 |
| Lilly USA, LLC | 11 | $202 |
| Amgen(2 entities) | 9 | $166 |
| Boehringer Ingelheim | 7 | $162 |
| Sunovion Pharmaceuticals Inc. | 8 | $160 |
| Redhill Biopharma Inc. | 9 | $153 |
| Merck | 10 | $140 |
| Amarin Pharma, Inc. | 7 | $134 |
| Biohaven Pharmaceuticals, Inc. | 6 | $117 |
| Novartis | 6 | $106 |
| Astellas Pharma US Inc | 5 | $98 |
| Neurocrine Biosciences, Inc. | 3 | $63 |
| Pfizer | 4 | $62 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Viiv Healthcare Company | 3 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Abbott | 2 | $32 |
| LEO Pharma Inc. | 2 | $28 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
How this compares
$5,785 in reported general payments places this provider in the 90th percentile of 4,321 family medicine providers in New York.
Other family medicine in Bronx
- Hui-Li HuangBronx$41K
- Mark HillBronx$37K
- Natalya RodionovaBronx$30K
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.